OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates

Core Insights - OraSure Technologies reported a quarterly loss of $0.18 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.15, and a decline from earnings of $0.04 per share a year ago, indicating an earnings surprise of -20% [1] - The company posted revenues of $29.93 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.73%, but down from $54.13 million in the same quarter last year [2] - OraSure shares have declined approximately 22.4% since the beginning of the year, contrasting with the S&P 500's decline of -4.7% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $33.46 million, and for the current fiscal year, it is -$0.40 on revenues of $136.26 million [7] - The estimate revisions trend for OraSure is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical - Products industry, to which OraSure belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment and stock performance [5]